Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial

We aimed to describe the mechanisms of immunological recovery and the effects of blocking CCR5 in patients starting ART with advanced HIV-infection. This was a sub-study of a 48 week double-blind, clinical trial where patients starting ART with CD4+ cell counts

Saved in:
Bibliographic Details
Published in:Pathogens & immunity 2017, Vol.2 (2), p.151-177
Main Authors: Belaunzarán-Zamudio, Pablo F, Azzoni, Livio, Canaday, David H, Caro-Vega, Yanink N, Clagett, Brian, Rassool, Mohammed S, Rodriguez, Benigno, Sanne, Ian, Sereti, Irini, Sierra-Madero, Juan G, Lederman, Michael M
Format: Article
Language:English
Subjects:
Immune Reconstitution Inflammatory Syndrome, HIV, maraviroc, immune activation, maturation phenotype
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We aimed to describe the mechanisms of immunological recovery and the effects of blocking CCR5 in patients starting ART with advanced HIV-infection. This was a sub-study of a 48 week double-blind, clinical trial where patients starting ART with CD4+ cell counts
ISSN:2469-2964
2469-2964
DOI:10.20411/pai.v2i2.181